Generation Bio Co.

Ownership Transactions Reported by 20 Insiders

Symbol
GBIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
301 Binney Street, Cambridge, MA

Insiders trading volume in the past year

Generation Bio Co. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Atlas Venture Fund X, L.P. 10%+ Owner $15.8M Sep 17, 2021
Geoff Mcdonough PRESIDENT AND CEO, Director $3.02M Apr 15, 2025
Matthew Stanton Chief Scientific Officer $1.37M Jan 10, 2025
Charles A. Rowland Jr Director $1.3M Jun 6, 2024
Matthew Norkunas Chief Financial Officer $880K Jan 10, 2025
Phillip Samayoa Chief Scientific Officer $788K Apr 15, 2025
Antoinette Paone Chief Operating Officer $750K -$18.4K -2.4% Apr 15, 2025
Douglas Kerr Chief Medical Officer $733K Jan 29, 2024
Donald William Nicholson Director $683K Jun 6, 2024
Anthony G. Quinn Director $566K +$203K +56.1% Jan 10, 2025
Yalonda Howze Chief Legal Officer $562K Apr 15, 2025
Dannielle Appelhans Director $314K Jun 6, 2024
Ronald Harold Wilfred Cooper Director $275K Jun 6, 2024
Catherine Stehman-Breen Director $275K Jun 6, 2024
Jeffrey M. Jonas Director $275K Jun 6, 2024
Gustav Christensen Director $275K Jun 6, 2024
Jason P. Rhodes Director $275K Jun 6, 2024
Tracy Zimmermann Chief Development Officer $93.4K Jan 29, 2024
Kevin John Conway Chief Financial Officer $10.2K Apr 15, 2025
Atlas Venture Associates X, L.P. 10%+ Owner $1.16K Sep 27, 2021

Recent Insider Transactions by Companies or Individuals for Generation Bio Co.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.